ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 2.35 USD 7.31% Market Closed
Market Cap: 57.1m USD

Wall Street
Price Targets

ABVC Price Targets Summary
ABVC Biopharma Inc

There are no price targets for ABVC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ABVC Biopharma Inc Competitors:
Price Targets
LCTX
Lineage Cell Therapeutics Inc
169% Upside
NTLA
Intellia Therapeutics Inc
128% Upside
ADCT
ADC Therapeutics SA
121% Upside
CUV
Clinuvel Pharmaceuticals Ltd
102% Upside
9996
Peijia Medical Ltd
58% Upside
300676
BGI Genomics Co Ltd
30% Upside
688331
RemeGen Co Ltd
17% Upside
ASMB
Assembly Biosciences Inc
35% Upside

Revenue
Forecast

Revenue Estimate
ABVC Biopharma Inc

For the last 12 years the compound annual growth rate for ABVC Biopharma Inc's revenue is 39%. The projected CAGR for the next 1 year is 735%.

39%
Past Growth
735%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ABVC Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
ABVC Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABVC's stock price target?
Not Available

ABVC doesn't have any price targets made by Wall Street professionals.

What is ABVC Biopharma Inc's Revenue forecast?
Projected CAGR
735%

For the last 12 years the compound annual growth rate for ABVC Biopharma Inc's revenue is 39%. The projected CAGR for the next 1 year is 735%.

Back to Top